Dawson B, Follenfant R L, Higgs G A, Schneider C, Gibson J R
Br J Dermatol. 1985 Jul;113 Suppl 28:137-40. doi: 10.1111/j.1365-2133.1985.tb15644.x.
We have examined the effects of various topical formulations of BW 540C, a novel dual inhibitor of the cyclo-oxygenase and lipoxygenase pathways of arachidonic acid metabolism, utilizing the model of ultraviolet irradiation of guinea-pig ears. During a series of studies, BW 540C preparations were compared with a range of corticosteroids, a cyclo-oxygenase inhibitor and a placebo using both subjective and objective measurements. Results showed BW 540C base to be the best overall agent for treating the pathological changes seen in this model.
我们利用豚鼠耳部紫外线照射模型,研究了新型花生四烯酸代谢环氧化酶和脂氧化酶途径双重抑制剂BW 540C的各种局部制剂的效果。在一系列研究中,使用主观和客观测量方法,将BW 540C制剂与一系列皮质类固醇、一种环氧化酶抑制剂和一种安慰剂进行了比较。结果表明,BW 540C基质是治疗该模型中所见病理变化的最佳总体药物。